At Oxford BioSystems we’ve observed that biomedical research increasingly relies on analysing multiple biomarkers at once. Whether studying immune responses, nutritional status, or complex disease pathways, running multiple single-analyte ELISAs can quickly become costly, time-consuming and sample-intensive.

The interleukin-2 receptor (IL-2R), also known as CD25, is a transmembrane protein, which is up-regulated on activated T-cells, and shed into serum as soluble IL-2R...

As laboratories strive to produce faster, more consistent and publication-quality immunoassay data, the need for advanced imaging technology has never been greater.